featured
Risk of Malignancy With Systemic Psoriasis Treatment
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Risk of Malignancy With Systemic Psoriasis Treatment in the Psoriasis Longitudinal Assessment Registry
J Am Acad Dermatol 2017 Sep 08;[EPub Ahead of Print], D Fiorentino, V Ho, MG Lebwohl, L Leite, L Hopkins, C Galindo, K Goyal, W Langholff, S Fakharzadeh, B Srivastava, RG LangleyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.